@article{b32e960315f84b5785cf5ec8a07134e2,
title = "Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect",
keywords = "Bone Diseases, Metabolic/drug therapy, Cholinergic Antagonists/adverse effects, Cognitive Dysfunction/complications, Fractures, Bone/drug therapy, Humans",
author = "\{CaMos Research Group\} and Dana Bliuc and Thach Tran and Adachi, \{Jonathan D\} and Atkins, \{Gerald J\} and Claudie Berger and \{van den Bergh\}, Joop and Roberto Cappai and Eisman, \{John A\} and \{van Geel\}, Tineke and Piet Geusens and David Goltzman and Hanley, \{David A\} and Robert Josse and Stephanie Kaiser and Kovacs, \{Christopher S\} and Lisa Langsetmo and Prior, \{Jerilynn C\} and Nguyen, \{Tuan V\} and Solomon, \{Lucian B\} and Catherine Stapledon and Center, \{Jacqueline R\}",
year = "2022",
month = may,
day = "1",
doi = "10.1002/jbmr.4530",
language = "English",
volume = "37",
pages = "1075--1076",
journal = "Journal of Bone and Mineral Research",
issn = "1523-4681",
publisher = "Wiley",
number = "5",
}